Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality Fudan University Shanghai Cancer Cancer, Shanghai, Shanghai Municipality